peu-MIR2916-p3-enriched garlic exosomes ameliorate murine colitis by reshaping gut microbiota, especially by boosting the anti-colitic Bacteroides thetaiotaomicron – Correspondence DOI Creative Commons

Xin-Zhi Huang,

Chin‐Yuan Yii, Su‐Boon Yong

et al.

Pharmacological Research, Journal Year: 2024, Volume and Issue: 202, P. 107131 - 107131

Published: March 2, 2024

Language: Английский

Plant extracellular vesicles: A promising bionic medicine platform for disease treatment and drug delivery DOI Creative Commons
Jichun Yang, Yuhan Wang,

Yunqian Fu

et al.

Deleted Journal, Journal Year: 2025, Volume and Issue: unknown

Published: March 20, 2025

Abstract Plant extracellular vesicles (PEVs) are nanoscale secreted by plant cells with intact membrane architecture, which encapsulate a diverse array of biomolecules, including lipids, proteins and RNA. They integral to both intra‐cellular communication within plants inter‐species signaling. Recently, some PEVs have been regarded as competitive candidates for disease therapy due their beneficial components distinctive hollow biomembrane structure. However, the broader applications currently impeded several challenges complicated extraction processes, compositional heterogeneity, lack reliable biomarkers unclear mechanisms. A detailed comprehension preparation techniques biological functions is essential leveraging potential in clinical medicine. This article first presented synthesis current methodologies PEV isolation, purification characterization. Then, it revealed therapeutic implications medicines common diseases based on bioactive molecules inside, such cancer, inflammation, metabolic disorders. We especially explored emerging role low immunogenicity power barriers crossing drug delivery systems, underscoring further industry applications. At last, bottleneck problems vision were also evoke more insightful deliberation. review aims provide directions development PEV‐derived innovative drugs.

Language: Английский

Citations

0

Bidirectional Interplay Among Non-Coding RNAs, the Microbiome, and the Host During Development and Diseases DOI Open Access

Shanshan Nai,

Ji‐Ying Song, Wenting Su

et al.

Genes, Journal Year: 2025, Volume and Issue: 16(2), P. 208 - 208

Published: Feb. 8, 2025

It is widely known that the dysregulation of non-coding RNAs (ncRNAs) and dysbiosis gut microbiome play significant roles in host development progression various diseases. Emerging evidence has highlighted bidirectional interplay between ncRNAs microbiome. This article aims to review current understanding molecular mechanisms underlying crosstalk ncRNAs, especially microRNA (miRNA), context diseases, such as colorectal cancer, inflammatory bowel neurological disorders, obesity, cardiovascular disease. Ultimately, this seeks provide a foundation for exploring potential interactions biomarkers therapeutic targets clinical diagnosis treatment, ncRNA mimics, antisense oligonucleotides, small-molecule compounds, well probiotics, prebiotics, diets.

Language: Английский

Citations

0

Host-dependent alteration of the gut microbiota: the role of luminal microRNAs DOI Open Access

Céline Cuinat,

Jianlin Pan,

Elena M. Comelli

et al.

Microbiome Research Reports, Journal Year: 2025, Volume and Issue: 4(1)

Published: Feb. 21, 2025

MicroRNAs (miRNAs) are short, non-coding RNAs that play gene expression regulatory roles in eukaryotes. MiRNAs also released body fluids, and the intestine, they found lumen feces. Here, together with exogenous dietary-derived miRNAs, constitute fecal miRNome. Several miRNAs were identified feces of healthy adults, including, as shown here, core hsa-miR-21-5p hsa-miR-1246. These important for intestinal homeostasis. Recent evidence suggests may interact gut bacteria. This represents a new avenue to understand host-bacteria crosstalk its role health disease. review provides comprehensive overview current knowledge on their representation across individuals, effects microbiota. It discusses existing potential mechanisms uptake interaction bacterial genomes, drawing from prokaryotic small (sRNAs) regulation expression. Finally, we silico experimental approaches profiling miRNA-mRNA interactions species, highlighting challenges target validation. work emphasizes need further research into host miRNA-bacterial better ecosystem support exploitation disease prevention treatment.

Language: Английский

Citations

0

Recent Advances in the Isolation Strategies of Plant-Derived Exosomes and Their Therapeutic Applications DOI Creative Commons

Jeong‐Geon Mun,

Dandan Song, Ji‐Ye Kee

et al.

Current Issues in Molecular Biology, Journal Year: 2025, Volume and Issue: 47(3), P. 144 - 144

Published: Feb. 22, 2025

Exosome-like nanovesicles (ELNs) derived from natural products are gaining attention as innovative therapeutic agents due to their biocompatibility, low immunogenicity, and capability transport bioactive molecules such proteins, lipids, nucleic acids. These plant-derived ELNs exhibit structural similarities with mammalian exosomes, making them suitable for drug delivery, microbiome-targeted therapies, regenerative medicine. Recent studies highlight potential in treating cancer, inflammation, metabolic disorders. Additionally, have applications cosmetics, agriculture, the food industry. This review combines latest advancements research on ELNs, focusing isolation techniques, pharmacological effects, applications. Although offer promising opportunities, several challenges must be addressed, including standardization, large-scale production, vivo efficacy. By summarizing cutting-edge suggesting future directions, we aim inspire further development of next-generation platforms.

Language: Английский

Citations

0

Nondigestible stachyose alleviates cyclophosphamide-induced small intestinal mucosal injury in mice by regulating intestinal exosomal miRNAs, independently of the gut microbiota DOI

Yuhang Hao,

Chennan Wang, Lu Wang

et al.

Food Research International, Journal Year: 2025, Volume and Issue: unknown, P. 116258 - 116258

Published: March 1, 2025

Language: Английский

Citations

0

Safety Profile of Solanum tuberosum-Derived Exosomes: Evidence from In Vitro Experiments and Human Skin Tests DOI Creative Commons
Yeji Lee, Radwa Hamdi Bakr Mohamed, Sanghwa Yang

et al.

Pharmaceuticals, Journal Year: 2025, Volume and Issue: 18(4), P. 458 - 458

Published: March 24, 2025

Background/Objectives: Potato (Solanum tuberosum)-derived exosomes (SDEs) are extracellular vesicles (66 nm in diameter) with therapeutic potential. SDEs suppress matrix metallopeptidases (MMPs) 1, 2, and 9, tumor necrosis factor (TNF), interleukin 6 (IL6), while exhibiting radical-scavenging activity against the free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) vitro mitigating hydrogen peroxide (H2O2)-induced oxidative stress HaCaT cells. upregulate antioxidant gene glutathione S-transferase alpha 4 (GSTA4), prevent UVB damage, regenerate photodamaged This study evaluates SDEs’ safety skin-enhancing properties to improve their beauty-related medical applications. Methods: The purified via ultracentrifugation were tested for cytotoxic effects on cell viability scratch wound healing assays skin barrier modulation keratinocytes Detroit 551 fibroblasts. A reverse transcription–polymerase chain reaction (RT-PCR) was used analyze changes expression following SDE treatment. Cosmetic prototypes containing assessed irritation, cooling effects, periorbital wrinkle reduction, elasticity, whitening properties. Results: cytotoxicity human topical tests confirmed of application. accelerated closure, elevated level, improved clinical parameters, including elasticity enhancement, whitening. No irritation or side observed. Conclusions: identified natural, edible potato-derived as highly safe agents that significantly enhance promote barrier-related expression. Their multifunctional anti-aging efficacy—reducing wrinkles, enhancing promoting without irritation—positions them promising candidates cosmetic dermatological innovations. These findings warrant further exploration applications, inflammatory disorders drug delivery systems.

Language: Английский

Citations

0

Advances in plant-derived vesicle like nanoparticles-based therapies for inflammatory diseases DOI Creative Commons
Zhifei Cheng, Wenbo Lu, Wei Shao

et al.

Asian Journal of Pharmaceutical Sciences, Journal Year: 2025, Volume and Issue: unknown, P. 101052 - 101052

Published: April 1, 2025

Language: Английский

Citations

0

Plant-based exosome-like extracellular vesicles as encapsulation vehicles for enhanced bioavailability and breast cancer therapy: recent advances and challenges DOI

Niraj Kumar Sah,

Sanchit Arora,

Rohan Chand Sahu

et al.

Medical Oncology, Journal Year: 2025, Volume and Issue: 42(6)

Published: April 28, 2025

Language: Английский

Citations

0

PD-L1 Antibody-Modified Plant-Derived Nanovesicles Carrying a STING Agonist for the Combinational Immunotherapy of Melanoma DOI
Zhanxue Xu,

Xinrui Yang,

Xingyu Lu

et al.

Biomaterials, Journal Year: 2025, Volume and Issue: unknown, P. 123396 - 123396

Published: May 1, 2025

Language: Английский

Citations

0

Plant-derived exosome-like nanoparticles – from Laboratory to factory, a landscape of application, challenges and prospects DOI

Chaozhi Wei,

Mengyu Zhang, Jintao Cheng

et al.

Critical Reviews in Food Science and Nutrition, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 19

Published: Aug. 11, 2024

Recent decades have witnessed substantial interest in extracellular vesicles (EVs) due to their crucial role intercellular communication across various biological processes. Among these, plant-derived exosome-like Nanoparticles (ELNs) rapidly gained recognition as highly promising candidates. ELNs, characterized by diverse sources, cost-effective production, and straightforward isolation, present a viable option for preventing treating numerous diseases. Furthermore, ELNs hold significant potential carriers natural or engineered drugs, enhancing attractiveness drawing considerable attention science medicine. However, translating into clinical applications poses several challenges. This study explores these challenges offers critical insights research directions. Additionally, it provides forward-looking analysis of the industrial prospects ELNs. With broad remarkable potential, stand at forefront biomedical innovation, poised revolutionize disease management drug delivery paradigms coming years.

Language: Английский

Citations

3